gamma-Aminobutyric Acid A Receptor Positive Modulator class drugs

3 results

  • ambien

    (zolpidem tartrate)
    sanofi-aventis U.S. LLC
    AMBIEN (zolpidem tartrate) is indicated for the short-term treatment of insomnia, specifically for difficulties with sleep initiation. It effectively reduces sleep latency for up to 35 days, as demonstrated in controlled clinical studies lasting 4–5 weeks.
    Medication Details
    Drug Interactions

  • ambien

    (zolpidem tartrate)
    sanofi-aventis U.S. LLC
    AMBIEN CR (zolpidem tartrate extended-release tablets) is indicated for the short-term treatment of insomnia, particularly for difficulties with sleep onset and/or maintenance, as measured by wake time after sleep onset. Clinical trials supporting its efficacy lasted up to 24 weeks.
    Medication Details
    Drug Interactions

  • zolpidem tartrate

    (Zolpidem Tartrate)
    Lupin Pharmaceuticals, Inc.
    Zolpidem tartrate extended-release tablets are indicated for the short-term treatment of insomnia, specifically for difficulties with sleep onset and/or maintenance, as measured by wake time after sleep onset.
    Medication Details
    Drug Interactions